Cyclin D1 Loss Distinguishes Prostatic Small Cell Carcinoma from Most Prostatic Adenocarcinomas

PURPOSE: Small cell neuroendocrine differentiation in prostatic carcinoma is an increasingly common resistance mechanism to potent androgen deprivation therapy (ADT), but can be difficult to identify morphologically. We investigated whether cyclin D1 and p16 expression can inform on Rb functional st...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Tsai, Harrison, Morais, Carlos L., Alshalalfa, Mohammed, Tan, Hsueh-Li, Haddad, Zaid, Hicks, Jessica, Gupta, Nilesh, Epstein, Jonathan I., Netto, George J., Isaacs, William B., Luo, Jun, Mehra, Rohit, Vessella, Robert L., Karnes, R. Jeffrey, Schaeffer, Edward M., Davicioni, Elai, De Marzo, Angelo M., Lotan, Tamara L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4681606/
https://ncbi.nlm.nih.gov/pubmed/26246306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-0744
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados